Oncology meetings & conferences

Nanotechnologies in Cancer Diagnosis, Therapy, and Prevention

June 11 - 13, 2013 Moscow, Russia

World Trade Center Moscow Congress Center

Presented by The New York Academy of Sciences, the Mushett Family Foundation, and the Skolkovo Institute of Science and Technology

Harnessing principles from chemistry, biology, physics, and engineering, nanotechnology is a multidisciplinary field still in its infancy. Throughout the past decade, nanoparticles and specifically nanoparticle drug delivery systems, have emerged at the forefront of cancer therapies.

Nanotechnology has helped to design and fabricate micro-scale devices, including nanoparticle drug delivery systems able to target tumors and other cancerous tissue. Nanotechnology is also being explored to generate other novel techniques to design biomarkers, immunotherapy, and vaccine development for cancer.

Featuring keynote address by Nobel Laureate Robert Y. Tsien, PhD, this 2.5-day conference will discuss: nanodiagnostics for cancer biomarkers and imaging, nanoparticle toxicity and safety; nanovaccines and nanoimmunotherapeutics; the challenges of targeted delivery in tumors; and nanoparticle-based gene therapy. A discussion of these topics will serve to enhance the translation of research discoveries into improved cancer diagnostic and treatment strategies.

International Symposium on Supportive Care in Cancer

June 27-29, 2013 Berlin, Germany

We have created a scientific program that focuses on new developments and challenges in supportive care, including topics of global interest and regional development.

Supportive care makes excellent cancer care possible and is itself supported by excellent science as we strive to enhance the lives of people on the cancer journey, at whatever stage they may find themselves.

The value of supportive care in cancer is increasingly being recognized, and the annual International Symposium is a wonderful place to learn, teach, communicate, network and share in the process of enhancing knowledge of supportive care and improving cancer care outcomes.

The Symposium will include discussion of methods to minimize cancer-induced side effects, the symptoms and complications of cancer treatment, and psychosocial issues facing cancer patients and their families.

Contact Us

Congress Organizer:

Kenes International
1-3 Rue de Chantepoulet, P.O. Box 1726, CH-1211
Geneva 1, Switzerland

Tel: +41 22 908 0488
Fax: +41 22 906 9140
E-mail: mascc@kenes.com

10th International Conference of the Society for Integrative Oncology

Translational Science in Integrative Oncology: “From Bedside, to Bench, to Best Practices”

Sunday, October 20, 2013 - Tuesday, October 22, 2013 Vancouver, BC, Canada

Presented by the Society for Integrative Oncology and Co-Sponsored by the University of British Columbia Division of Continuing Professional Development, Faculty of Medicine and the University of British Columbia School of Nursing.

The conference will include keynote speakers, plenary and concurrent sessions, and workshops that will highlight the latest research evidence, methodological issues, and dialogue in the field of integrative oncology.

Up Close and Personalized, International Congress on Personalized Medicine

July 25-28, 2013 Paris, France

Personalized Medicine is revolutionizing the medical world. Understanding and integrating genetic and molecular information with traditional clinical knowledge is the hallmark of this transformation. At present much of the medical practice is based on standards of care derived from the epidemiologic studies of large cohorts that do not take into account the individual’s genetic, proteomic, and metabolic characteristics. Furthermore, in spite of efforts to develop data-driven, expert–based, clinical decision support systems, there are no clear and simple means to disseminate new findings into clinical practice.

Following the great success of the meeting in Florence Italy last year, the main focus of the second Up Close and Personalized Congress is to examine the essential clinical, imaging, genomic, proteomic, metabolomic, pharmacogenomic and biomarker data necessary to predict, prevent and treat major medical conditions concerning metabolism (diabetes and obesity) and cancer. As in the first meeting one of the key themes will be to explore bio-informatic tools, algorithms, decision support systems and other new platforms for disease prediction and better tailoring treatment modeling to the individual patient. Furthermore, we will discuss health policy issues such as barriers for implementing Personalized Medicine, and quality assurance.

Topics

Diabetes
Diagnostics
Health Policy
Imaging
Informatics
Obesity
Oncology

Contact Us

Please do not hesitate to contact us with any questions or queries on Up Close and Personalized – The 2nd International Congress on Personalized Medicine.

Congress Secretariat
Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel: +41 (0) 22 5330 948
Fax: +41 (0) 22 5802 953
Email: Secretariat@upcp.org

2nd World Congress on Thyroid Cancer

July 10-14, 2013 Toronto, Canada

The 2nd WCTC is a global multi-disciplinary meeting of all specialists involved in the field of Thyroid Cancer. Join us at this cutting-edge, state-of-the-art, multidisciplinary Congress covering the entire spectrum of thyroid nodules and thyroid cancer. The Congress program focuses on the most recent advances in this field and will appeal to a broad audience of specialists. The scientific program includes keynotes, lectures, panels, workshops, instructional courses, meet the professors, video sessions, auxiliary symposiums, scientific and commercial exhibits.  A full social program each evening provides the opportunity to network with colleagues and international experts.

North American Association of Central Cancer Registries (NAACCR) 2013 Annual Conference

June 8-14, 2013 Austin, Texas

This year’s conference, “Thinking Big: The Future of Cancer Surveillance,” will explore innovative and creative ideas for how science, technology, policy, and collaboration can shape the future of cancer surveillance. Sessions will address future directions, both realized and potential, from multiple perspectives on cancer surveillance in North America.

For more information, please contact info@naaccr.org.

3rd World Congress of the International Society for Fertility Preservation (ISFP)

November 7-9, 2013 Valencia, Spain

We invite you to take part in the 3rd World Congress on the International Society for Fertility Preservation (ISFP) which will take place in Valencia, Spain on November 7-9, 2013.

Fertility preservation is a substantial quality of life issue for young cancer survivors. As a consequence, the demand for fertility preservation has dramatically increased. The aim of the Congress is to update current scientific and clinical development of fertility preservation strategies. The Congress will not only propagate the current knowledge but also provide an opportunity for networking.

This congress is designed for reproductive endocrinologists, hematology-oncologists, gynecologic oncologists, psychologists, basic scientists, clinical researchers, oncology nurses, REI nurses, oncology social workers and others interested in fertility preservation.

During this congress, participants will be able to:

- Educate medical professionals to facilitate FP referrals
- Define the ethical and legal issues related to FP
- Explain the impact of cancer treatment on fertility and reproduction.
- Evaluate the current status of gamete Cryopreservation.
- Assess the strategies and values of emerging technology in ovarian transplantation.
- Recognize basic physiology and effects of Cryopreservation.
- Analyze physiology and current techniques of folliculogenesis and IVM.
- Identify new fertility preservation technologies

National Cancer Registrars Association's 39th Annual Education Conference

May 30-June 2, 2013 San Francisco, California

European Association of Neurosurgical Societies Annual Meeting 2013

November 11-14, 2013 Tel Aviv, Israel

EANS 2013 will provide you with unparalleled access to the latest research and newest perspectives in the field of neurosurgery. For the first time, EANS will co-host the meeting with the American Association of Neurological Surgeons and the Congress of Neurological Surgeons (AANS/CNS) Section on Tumors, and the Annual International Neuro-Oncology Updates, bringing together the best of two continents.

Kenes Internatonal
1-3, rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
E-mail: eans2013@kenes.com

4th International Congress on Biomarkers & Clinical Research

July 16-17, 2013 Philadelphia, Pennsylvania

OMICS Group invites scientific communities, students, delegates and business executives to give their latest biomarker developments and its application in health diagnostics and in clinical research through oral and poster presentations and clinical case studies across the globe to attend 4th International Congress on Biomarkers & Clinical Research, during July 16-17, 2013 at Double Tree by Hilton Philadelphia Center City, USA, that can demonstrate the evidence from research and clinical application in Biomarker discovery and its potential application in clinical practice. Special interest and theme of this conference is “Impact of Biomarkers Development in Health Diagnostics and Clinical Research”.

The previous three conferences on Biomarkers which were held at Santa Clara, USA (2010), Baltimore, USA (2011) and Embassy Suites Las Vegas, USA (2012) have explained Strategies and Developments in Biomarkers and why its disease identification strategies have gained so much interest for eminent scientists all over the world in Pharmaceutical R&D.

Biomarkers-2013 focuses on the development and application of biomarkers as key role indicators in health diagnostics, has become a central strategy in a general re-evaluation of drug discovery processes and points the way to major changes in health diagnostics and clinical research. This two day conference, assembles leading scientists, researchers, decision-makers and other players across the industry spectrum, that provides a unique opportunity to gain the latest biomarker developments and its application in health diagnostics, oncology and in clinical research.

Topics include

Types of Biomarkers and Approaches
Biomarkers: Data Analysis
Biomarkers in Clinical Research and Development
Biomarkers: Molecular Approaches
Omics Technologies in Biomarkers Discovery and Validation
Biomarkers of Exposure, Response, and Susceptibility
Enabling Technologies to Maximize Biomarker Identification
Biomarkers: Disorders
Biomarkers in Microbial Infections
Biomarkers and Nanoparticles
Current Research Concepts in Biomarkers